Fabiani, Emiliano
 Distribuzione geografica
Continente #
EU - Europa 1.894
NA - Nord America 1.646
AS - Asia 424
SA - Sud America 14
AF - Africa 11
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.997
Nazione #
US - Stati Uniti d'America 1.637
DE - Germania 814
SE - Svezia 380
CN - Cina 324
UA - Ucraina 161
IT - Italia 114
PL - Polonia 106
FR - Francia 92
IE - Irlanda 82
IN - India 47
GB - Regno Unito 43
FI - Finlandia 34
BE - Belgio 28
JP - Giappone 13
TR - Turchia 11
CI - Costa d'Avorio 9
CA - Canada 8
NL - Olanda 8
AU - Australia 6
IR - Iran 6
KR - Corea 6
VN - Vietnam 6
BR - Brasile 5
CO - Colombia 5
AT - Austria 4
CZ - Repubblica Ceca 4
CH - Svizzera 3
ES - Italia 3
GR - Grecia 3
NO - Norvegia 3
RU - Federazione Russa 3
TH - Thailandia 3
HK - Hong Kong 2
HR - Croazia 2
ID - Indonesia 2
A1 - Anonimo 1
AR - Argentina 1
BG - Bulgaria 1
BO - Bolivia 1
CL - Cile 1
EG - Egitto 1
EU - Europa 1
HU - Ungheria 1
IL - Israele 1
IS - Islanda 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
ME - Montenegro 1
MK - Macedonia 1
MX - Messico 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
TN - Tunisia 1
Totale 3.997
Città #
Chandler 352
Jacksonville 118
Warsaw 105
Dearborn 92
Nanjing 85
Houston 82
Ashburn 78
San Mateo 78
Dublin 77
Ann Arbor 72
Woodbridge 55
Wilmington 53
Fairfield 43
Nürnberg 41
Bremen 38
Milan 38
Nanchang 31
Beijing 29
Brussels 27
Lawrence 27
Redwood City 27
Seattle 27
Boston 22
Marseille 20
Cattolica 18
Chatsworth 16
Kunming 16
Shanghai 16
Hangzhou 15
Leawood 14
Munich 14
Auburn Hills 13
Changsha 13
Guangzhou 13
Hefei 13
Zhengzhou 13
Shenyang 12
Cambridge 11
Princeton 11
Pune 11
Chicago 10
Los Angeles 10
Mountain View 10
Abidjan 9
Jiaxing 9
Tianjin 9
University Park 9
Augusta 8
Fremont 8
Hebei 8
Izmir 8
Jinan 8
Lanzhou 7
Boardman 6
Edinburgh 6
Enterprise 6
Rome 6
Costa Mesa 5
Hanoi 5
London 5
Monmouth Junction 5
Norwalk 5
Simi Valley 5
Washington 5
Lancaster 4
Medellín 4
San Jose 4
Seoul 4
Andover 3
Chengdu 3
Dallas 3
Falls Church 3
Indiana 3
New Delhi 3
Oslo 3
Redmond 3
Richardson 3
San Diego 3
São Paulo 3
Taizhou 3
Tokyo 3
Vienna 3
Örebro 3
Atlanta 2
Barcelona 2
Buffalo 2
Changchun 2
Chongqing 2
Clearwater 2
Frankfurt Am Main 2
Fuzhou 2
Hong Kong 2
Kish 2
Miami 2
Netherby 2
Ningbo 2
Phoenix 2
Romainville 2
Sydney 2
Toronto 2
Totale 2.103
Nome #
Fanconi anemia gene variants in therapy-related myeloid neoplasms 248
Mutational analysis of bone marrow mesenchymal stromal cells in myeloid malignancies 190
MUTATIONAL ANALYSIS OF BONE MARROW MESENCHIMAL STROMAL CELLS IN MYELOID MALIGNANCIES 157
PTEN/PI3K/AKT PATHWAY DYSREGULATION IN MYELODYSPLASTIC GRANULOCYTES 154
GSK3β down-regulation in Mesenchymal Stem Cells from patients with Myelodysplastic Syndrome. 146
DEREGULATION OF PI3K/AKT SIGNALING IN BONE MARROW MESENCHIMAL STROMAL CELLS FROM PATIENTS WITH DE NOVO AND THERAPY-RELATED ACUTE MYELOID LEUKEMIA 128
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 127
Why methylation is not a marker predictive of response to hypomethylating agents 127
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the italian network on secondary leukemias. 127
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 125
MTHFR polymorphysms in myelodysplastic syndromes and therapy-related myeloid neoplasms 125
SETBP1 mutations in 106 patients with therapy-related myeloid neoplasms. 124
Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia 120
Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes. 115
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 114
Analysis of genome-wide methylation and gene expression induced by 5-aza-2'-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia. 112
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 111
Similarities and differences between therapy-related and elderly acute myeloid leukemia 106
Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine 104
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 101
Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes 99
5-azacytidine in chronic myelomonocytic leukemia: case report and review of literature 98
Epigenetic changes in therapy-related MDS/AML 96
Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-azacytidine 94
Prognostic role of glutathione S-transferase polymorphisms in acute myeloid leukemia. 91
PU.1 and CEBPA expression in acute myeloid leukemia. 88
Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk myelodysplastic syndromes. 86
Clonal evolution in therapy-related neoplasms 80
The BCL2L10 Leu21Arg variant and risk of therapy-related myeloid neoplasms and de novo myelodysplastic syndromes 79
Development of a High-Resolution Melting Curve Analysis Screening Test for SRSF2 Splicing Factor Gene Mutations in Myelodysplastic Syndromes 75
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 70
Transcription factors implicated in late megakaryopoiesis as markers of outcome after azacitidine and allogeneic stem cell transplantation in myelodysplastic syndrome 70
Endothelial progenitor cell dysfunction in myelodysplastic syndromes: possible contribution of a defective vascular niche to myelodysplasia 69
Children with special health care needs attending emergency department in Italy: analysis of 3479 cases 68
Myelodysplastic disorders carrying both isolated del(5q) and JAK2(V617F) mutation: concise review, with focus on lenalidomide therapy 65
Therapy-related myeloid neoplasms: Clinical perspectives 52
In vitro Effect of Eltrombopag Alone and in Combination With Azacitidine on Megakaryopoiesis in Patients With Myelodysplastic Syndrome 43
Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1/ETO-positive leukemia cells 41
Totale 4.025
Categoria #
all - tutte 9.521
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.521


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019268 0 0 0 0 0 36 62 31 28 46 38 27
2019/2020728 117 42 51 61 85 116 52 22 62 38 40 42
2020/2021546 18 37 10 38 57 59 93 7 47 45 114 21
2021/2022392 45 39 5 11 31 19 5 76 17 40 49 55
2022/2023967 140 144 77 181 56 99 41 94 78 4 39 14
2023/2024219 23 112 13 16 21 34 0 0 0 0 0 0
Totale 4.025